Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00375791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
ClinicalTrials.gov study NCT01091883. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging
ClinicalTrials.gov study NCT01780766. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
ClinicalTrials.gov study NCT06252792. IPD Sharing: UNDECIDED. Countries: 0. Publications: 27.
Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
ClinicalTrials.gov study NCT06302699. IPD Sharing: NO. Countries: 1. Publications: 1.
Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01701076. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03720041. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01568294. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03782064. IPD Sharing: YES. Countries: 1. Publications: 0.
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00006021. IPD Sharing: Not stated. Countries: 1. Publications: 1.
NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04136756. IPD Sharing: NO. Countries: 1. Publications: 2.
Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02410694. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy
ClinicalTrials.gov study NCT05675319. IPD Sharing: NO. Countries: 1. Publications: 1.
Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03140943. IPD Sharing: Not stated. Countries: 4. Publications: 1.
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
ClinicalTrials.gov study NCT03093168. IPD Sharing: YES. Countries: 1. Publications: 1.
Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
ClinicalTrials.gov study NCT00376883. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02199665. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02103335. IPD Sharing: NO. Countries: 2. Publications: 21.
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov study NCT00391157. IPD Sharing: Not stated. Countries: 1. Publications: 29.
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
ClinicalTrials.gov study NCT03975907. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.